109
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Adoptive immunotherapy, chemotherapy, and second allogeneic transplant in the treatment of post-transplant relapse of acute leukemia in children: a single center experience

, , , , &
Pages 1936-1940 | Received 15 Feb 2010, Accepted 23 Jun 2010, Published online: 17 Sep 2010

References

  • Eapen M, Giralt SA, Horowitz MM, et al Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. Bone Marrow Transplant 2004;34:721–727.
  • Meshinchi S, Leisenring WM, Carpenter PA, et al Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia. Biol Blood Marrow Transplant 2003;9:706–713.
  • Michallet M, Tanguy ML, Socié G, et al Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Francaise de Greffe de moelle (SFGM). Br J Haematol 2000;108:400–407.
  • Arellano ML, Langston A, Winton E, Flowers CR, Waller EK. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience. Biol Blood Marrow Transplant 2007;13:116–123.
  • Hartwig M, Ocheni S, Asenova S, et al Second allogeneic stem cell transplantation in myeloid malignancis. Acta Haematol 2009;122:185–192.
  • Shaw BE, Mufti GJ, Mackinnon S, et al Outcome of second allogeneic transplants using reduced intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant 2008;42:783–789.
  • Formankova R, Honzatkova L, Sieglova Z, Stary J, Sedlacek P, Brdicka R. Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia. Bone Marrow Transplant 2000;25:453–456.
  • Formankova R, Sedlacek P, Krskova L, Rihova H, Sramkova L, Stary J. Chimerism-directed adoptive immunotherapy in the prevention and treatment of post-transplant relapse of leukemia in childhood. Haematologica 2003;87:121–122.
  • Sramkova L, Muzikova K, Fronkova E, et al Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;48:93–100.
  • Locatelli F, Testi AM, Bernardo ME, et al Clofarabine, cyclophosphamide and etoposide as single course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukemia. Br J Haematol 2009; 147:371–378.
  • Bader P, Klingebiel T, Schaudt A, et al Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia 1999;13:2079–2086.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.